Earningsreport

Q4/2023 12/31/2023 EPS -0.540 ZacksConsensus -0.340 ActVsEst (0.200) - Miss

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors